Global Bio-Pharma Competitive Landscape Professional Research Report 2024

Research Summary

Bio-pharma, short for biopharmaceuticals, refers to pharmaceutical drugs that are produced using biotechnology techniques and processes. Bio-pharmaceuticals are derived from living organisms, such as cells or microorganisms, and include various types of proteins, peptides, antibodies, and nucleic acids. They are distinct from traditional pharmaceuticals, which are typically synthesized through chemical processes. Bio-pharmaceuticals are developed through the use of recombinant DNA technology, genetic engineering, and other biotechnological methods. These drugs offer targeted therapies and can be more effective and safer than conventional drugs in certain cases. Bio-pharma products have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, genetic diseases, and infectious diseases. They are subject to rigorous regulatory oversight to ensure their safety, efficacy, and quality. Bio-pharma represents a rapidly growing sector in the pharmaceutical industry, with ongoing advancements in biotechnology contributing to the development of innovative therapies and personalized medicine approaches.

According to DIResearch's in-depth investigation and research, the global Bio-Pharma market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Bio-Pharma include Pfizer, F. Hoffmann-La Roche, Johnson & Johnson Services, Sanofi, Amgen, AbbVie, Merck, Biogen Idec, Bayer, Eli Lilly and Company, Novartis, GlaxoSmithKline, Bristol-Myers Squibb Company, AstraZeneca Abbott LaboratoriesSun etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Bio-Pharma. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bio-Pharma market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Bio-Pharma market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bio-Pharma industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Bio-Pharma Include:

Pfizer

F. Hoffmann-La Roche

Johnson & Johnson Services

Sanofi

Amgen

AbbVie

Merck

Biogen Idec

Bayer

Eli Lilly and Company

Novartis

GlaxoSmithKline

Bristol-Myers Squibb Company

AstraZeneca Abbott LaboratoriesSun

Bio-Pharma Product Segment Include:

Monoclonal Antibodies

Recombinant Proteins

Granulocyte-Colony Stimulating Factor (G-CSF)

Interferons

Recombinant Human Insulin

Erythropoietin

Vaccines

Growth Hormones

Purified Proteins

Others

Bio-Pharma Product Application Include:

Metabolic Disorders

Oncology

Neurological Disorders

Cardiovascular Diseases

Inflammatory and Infectious Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Bio-Pharma Industry PESTEL Analysis

Chapter 3: Global Bio-Pharma Industry Porter's Five Forces Analysis

Chapter 4: Global Bio-Pharma Major Regional Market Size and Forecast Analysis

Chapter 5: Global Bio-Pharma Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Bio-Pharma Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Bio-Pharma Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Bio-Pharma Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Bio-Pharma Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Bio-Pharma Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Bio-Pharma Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Bio-Pharma Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Bio-Pharma Market Overview

1.1 Product Definition and Statistical Scope

1.2 Bio-Pharma Product by Type

1.2.1 Global Bio-Pharma Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Recombinant Proteins

1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)

1.2.5 Interferons

1.2.6 Recombinant Human Insulin

1.2.7 Erythropoietin

1.2.8 Vaccines

1.2.9 Growth Hormones

1.2.10 Purified Proteins

1.2.11 Others

1.3 Bio-Pharma Product by Application

1.3.1 Global Bio-Pharma Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Metabolic Disorders

1.3.3 Oncology

1.3.4 Neurological Disorders

1.3.5 Cardiovascular Diseases

1.3.6 Inflammatory and Infectious Diseases

1.3.7 Others

1.4 Global Bio-Pharma Market Revenue Analysis (2019-2030)

1.5 Bio-Pharma Market Development Status and Trends

1.5.1 Bio-Pharma Industry Development Status Analysis

1.5.2 Bio-Pharma Industry Development Trends Analysis

2 Bio-Pharma Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Bio-Pharma Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Bio-Pharma Market Analysis by Regions

4.1 Bio-Pharma Overall Market: 2023 VS 2024 VS 2030

4.2 Global Bio-Pharma Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Bio-Pharma Revenue and Market Share by Region (2019-2024)

4.2.2 Global Bio-Pharma Revenue Forecast by Region (2025-2030)

5 Global Bio-Pharma Market Size by Type and Application

5.1 Global Bio-Pharma Market Size by Type

5.2 Global Bio-Pharma Market Size by Application

6 North America

6.1 North America Bio-Pharma Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Bio-Pharma Market Size by Type

6.4 North America Bio-Pharma Market Size by Application

6.5 North America Bio-Pharma Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Bio-Pharma Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Bio-Pharma Market Size by Type

7.4 Europe Bio-Pharma Market Size by Application

7.5 Europe Bio-Pharma Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Bio-Pharma Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Bio-Pharma Market Size by Type

8.4 China Bio-Pharma Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Bio-Pharma Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Bio-Pharma Market Size by Type

9.4 APAC (excl. China) Bio-Pharma Market Size by Application

9.5 APAC (excl. China) Bio-Pharma Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Bio-Pharma Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Bio-Pharma Market Size by Type

10.4 Latin America Bio-Pharma Market Size by Application

10.5 Latin America Bio-Pharma Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Bio-Pharma Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Bio-Pharma Market Size by Type

11.4 Middle East & Africa Bio-Pharma Market Size by Application

11.5 Middle East & Africa Bio-Pharma Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Bio-Pharma Market Revenue by Key Manufacturers (2020-2024)

12.2 Bio-Pharma Competitive Landscape Analysis and Market Dynamic

12.2.1 Bio-Pharma Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Pfizer

13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Pfizer Bio-Pharma Product Portfolio

13.1.3 Pfizer Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 F. Hoffmann-La Roche

13.2.1 F. Hoffmann-La Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 F. Hoffmann-La Roche Bio-Pharma Product Portfolio

13.2.3 F. Hoffmann-La Roche Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Johnson & Johnson Services

13.3.1 Johnson & Johnson Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Johnson & Johnson Services Bio-Pharma Product Portfolio

13.3.3 Johnson & Johnson Services Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Sanofi

13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Sanofi Bio-Pharma Product Portfolio

13.4.3 Sanofi Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Amgen

13.5.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Amgen Bio-Pharma Product Portfolio

13.5.3 Amgen Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 AbbVie

13.6.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 AbbVie Bio-Pharma Product Portfolio

13.6.3 AbbVie Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Merck

13.7.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Merck Bio-Pharma Product Portfolio

13.7.3 Merck Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Biogen Idec

13.8.1 Biogen Idec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Biogen Idec Bio-Pharma Product Portfolio

13.8.3 Biogen Idec Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Bayer

13.9.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Bayer Bio-Pharma Product Portfolio

13.9.3 Bayer Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Eli Lilly and Company

13.10.1 Eli Lilly and Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Eli Lilly and Company Bio-Pharma Product Portfolio

13.10.3 Eli Lilly and Company Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Novartis

13.11.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Novartis Bio-Pharma Product Portfolio

13.11.3 Novartis Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 GlaxoSmithKline

13.12.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 GlaxoSmithKline Bio-Pharma Product Portfolio

13.12.3 GlaxoSmithKline Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Bristol-Myers Squibb Company

13.13.1 Bristol-Myers Squibb Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Bristol-Myers Squibb Company Bio-Pharma Product Portfolio

13.13.3 Bristol-Myers Squibb Company Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 AstraZeneca Abbott LaboratoriesSun

13.14.1 AstraZeneca Abbott LaboratoriesSun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 AstraZeneca Abbott LaboratoriesSun Bio-Pharma Product Portfolio

13.14.3 AstraZeneca Abbott LaboratoriesSun Bio-Pharma Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Bio-Pharma Industry Chain Analysis

14.2 Bio-Pharma Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Bio-Pharma Typical Downstream Customers

14.4 Bio-Pharma Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support